<DOC>
	<DOCNO>NCT01825798</DOCNO>
	<brief_summary>The purpose study determine whether metformin safe effective treatment weight weight gain young people Autism Spectrum Disorders ( ASD ) currently take atypical antipsychotic medication .</brief_summary>
	<brief_title>Treatment Overweight Induced Antipsychotic Medication Young People With Autism Spectrum Disorders ( ASD )</brief_title>
	<detailed_description>This double-blind , placebo-controlled , multi-site randomize trial evaluate oral fix dose metformin ( RiometÂ® ) decrease weight weight gain child age 6-17 year , 4 month ASD currently take atypical antipsychotic medication . A 16-week , double-blind , placebo-controlled randomize trial metformin dose guide age conduct . A secondary study aim ass long-term safety efficacy metformin conduct 16-week open label continuation .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>1 . Diagnosis Autism Spectrum Disorder ( autistic disorder , pervasive developmental disorder otherwise specify ) , Asperger 's disorder ) base upon Autism Diagnostic Observation Scale ( ADOS ) Diagnostic Statistical Manual ( DSMIV ) interview . 2 . Minimum 1 month stable atypical antipsychotic dose plan change dose next 4 month . 3 . A documented great than/equal 7 % increase BMI since start atypical antipsychotic therapy ( go back far prior 12 month ) ; , BMI great equal 85th percentile correct age sex , great 5 % body weight increase per year ( prorate great 5 % body weight increase medicate long year ) . 4 . Age 6 year 17 year , 4 month . 5 . Subjects parent ( guardian ) must judge reliable medication compliance must agree keep appointment study visit test outline protocol . 6 . Prior conduct studyspecific procedure , subject must provide assent participate study ( developmentally appropriate ) , parent ( guardian ) must provide write informed consent . 1 . History intolerable adverse effect metformin . 2 . Prior history exposure metformin sufficient dose duration determine response status . 3 . History liver disease , renal impairment , congestive heart failure , pernicious anemia , condition increase risk lactic acidosis , serious medical illness require treatment . 4 . Use cationic drug excrete kidney . 5 . Planned surgery procedure require contrast . 6 . Pregnant screen contact . 7 . On psychotropic concomitant medication less 2 month . 8 . Treatment plan treatment concomitant medication unacceptable interaction metformin , include topiramate , levetiracetam , beta blocker , angiotensinconvertingenzyme ( ACE ) inhibitor , diuretic , histamine H2 receptor antagonist . 9 . Unable tolerate blood work . 10 . Current use medication target symptom appetite weight loss . 11 . Planned change medication , medication dose , behavioral treatment target weight loss study period .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Overweight</keyword>
	<keyword>Atypical Antipsychotic</keyword>
	<keyword>Medication</keyword>
	<keyword>Randomized Clinical Trial</keyword>
	<keyword>Children</keyword>
</DOC>